Effectiveness Of HDtDCS In Cognitive And Negative Symptoms Of Schizophrenia measured Using fMRI
Phase 3
Not yet recruiting
- Conditions
- Schizophrenia,
- Registration Number
- CTRI/2021/07/034759
- Lead Sponsor
- Central Institute Of Psychiatry
- Brief Summary
Schizophrenia is a chronic debilitating condition where the negative and cognitive symptoms cause functional impairment even after positive symptoms resolve. High definition transcranial direct current stimulation is a non invasive and cost effective neuomodulatory technique with promising results for negative and chronic symptoms of schizophrenia. HDtDCS is a technically enhanced version of tDCS giving a more focal stimulation and has a better predictive stimulation output which will be assessed on clinical rating scales and fMRI.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
- 1.Diagnosis of Schizophrenia using Diagnostic Criteria for Research (DCR) of International Classification of Disease-10th edition (ICD-10, World Health Organization,1992) 2.Duration of illness to be more than or equal to two years.
- 3.Age between 18- 60 years of either sex 4.The Positive and Negative Syndrome Scale for Schizophrenia (PANSS) negative symptoms score of more than 15 5.Scale for Assessment of Negative Symptoms (SANS) score more than 20 6.Right-handed 7.Educated upto class VIII or above 8.Patients giving written informed consent.
Exclusion Criteria
- 1.Presence of co-morbid neurological or other psychiatric disorder(s).
- 2.Patient with co morbid substance dependence, except nicotine and caffeine.
- 3.Having any metallic implants/parts in body 4.Subjects who have received ECT in past 6 months.
- 5.Colour blind.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Reduction in scores on negative and cognitive symptoms after application of HDtDCS. 1. At baseline | 2. At the end of 2 weeks | 3. At the end of 4 weeks
- Secondary Outcome Measures
Name Time Method Change in fMRI activation of Pre Frontal Cortex using cognitive task and change in resting state functional connectivity at baseline and after application of HDtDCS. 1. At baseline
Trial Locations
- Locations (1)
Central Institute Of Psychiatry
🇮🇳Ranchi, JHARKHAND, India
Central Institute Of Psychiatry🇮🇳Ranchi, JHARKHAND, IndiaBhawna YadavPrincipal investigator9650618113bhawnayadav1712@gmail.com